Rudower Chaussee 29
12489, Berlin, Germany
Epimune Diagnostics develops and produces i.Mune™ in-vitro diagnostic tests for early detection and management of immune disorders. Using revolutionary epigenetic immune cell quantification from dried blood spots, we enable home-based self-sampling, newborn screening and patient management in regions with limited fresh blood sample logistics. Our i.Mune™ TBNK (CE) IVD test allows quantification of CD3+, CD4+, CD8+ T-, B- and NK cells (lymphocytes) in liquid venous whole blood and capillary whole blood dried on filter paper (Dried Blood Spot; DBS).
A total of 22 different epigenetic immune cell quantification assays are available for research use (see: https://www.epimune-dx.com/english/research/).